A Frequency of fimA Genotypes of P. gingivalis in Rheumatoid Arthritis Patients and Control group.
Genotypes of P. gingivalis in Rheumatoid Arthritis
DOI:
https://doi.org/10.46966/msjar.v4i3.140Keywords:
Anti-cyclic Citrullinated Peptide, Disease Activity Score-28 (DAS28), Interleukin-17, Porphyromonas gingivalis, Rheumatoid arthritis.Abstract
Rheumatoid arthritis (RA): Chronic inflammatory polyarthritis, an autoimmune response targeting citrullinated antigens, due to destructive synovial joint inflammation. Porphyromonas gingivalis, a gram-negative bacterium residing in the subgingival tissues of the oral cavity, has been implicated in the association with RA, mainly due to the identification of a bacterial enzyme known as peptidyl arginine deaminase (PAD). The presence of this enzyme in P. gingivalis suggests its potential role in RA development by generating citrullinated antigens. Aims: The association between P. gingivalis and the development of anticitrullinated peptide antibody (ACPA) and if its role as an environmental risk factor of RA. Methods: This case-control study involved a total 140 participants, collection of blood and gingival crevicular fluid (GCF) samples from the participants, various tests were conducted, Specific PCR primers targeting fimA genotypes of P. gingivalis were utilized to amplify the relevant genetic regions.Statistical analysis used: Statistical Package for the Social Sciences (SPSS) version 26, a T-test and Chi-square (χ^2) test were utilized. Results: The p-values for ESR, ACCP, and IL-17 were 0.0001, 0.02, and 0.0001, respectively, indicating strong statistical significance for RA patients. Among the RA patients with P. gingivalis infection and the RA patients without P. gingivalis infection the analysis did not reveal a statistically significant difference in mean of ACCP and all biomarkers between the two groups (p-value=1.000) Conclusions: No association between P. gingivalis and the development of ACPA, the rise in ESR levels as disease severity escalates underscores the potential practicality of using ESR as an indicator to evaluate disease activity in RA, a trend towards a higher occurrence of gum problems among RA patients especially in category of patients developed gum problems before the onset of RA.
References
-Ali,G.,A. Evaluation and Comparison Value of Some Immuno marker in Rheumatoid Arthritis Patients . Master’s thesis. College of Medicine University of Kufa, 2022.
-Castellar-Mendoza, C., Castillo, D. M., Chila-Moreno, L., Bautista-Molano, W., & Romero-Sánchez, C. Porphyromonas gulae and PPAD antibodies are not related to citrullination in rheumatoid arthritis. Clinical Oral Investigations, 2023;1-11.
-Groeger, S., Wu, F., Wagenlehner, F., Dansranjav, T., Ruf, S., Denter, F., & Meyle, J. PD-L1 up-regulation in prostate cancer cells by Porphyromonas gingivalis. Frontiers in Cellular and Infection Microbiology, 2022; 12, 935806.
-Law, S. C., Street, S., Yu, C. H. A., Capini, C., Ramnoruth, S., Nel, H. J., ... & Thomas, R. T-cell autoreactivity to citrullinated autoantigenic peptides in rheumatoid arthritis patients carrying HLA-DRB1 shared epitope alleles. Arthritis research & therapy, 2012;14(3), 1-12.
-Cheng, Z., Do, T., Mankia, K., Meade, J., Hunt, L., Clerehugh, V., ... & Devine, D. Dysbiosis in the oral microbiomes of anti-CCP positive individuals at risk of developing rheumatoid arthritis. Annals of the Rheumatic Diseases, 2021, 80(2), 162-168.
-Mangat, P., Wegner, N., Venables, P. J., & Potempa, J. Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis?. Arthritis research & therapy, 2010; 12, 1-9.
- Alnasrawy, A. A., Alsalihi, A. A., Abo Almaali, H. M., & Al-Khafaji, Y. A. Porphyromonas gingivalis fimA genotyping in adult periodontitis population in Kerbala city. kerbala journal of pharmaceutical sciences, 2014; (8).
-Hachim, S. K., Abbas, A. A., & Alosami, M. H. Association of Porphyromonus gingivalis with Rheumatoid arthritis. Iraqi Journal of Medical Sciences, 2016; 14(3).
-Cheng, Z., Do, T., Mankia, K., Meade, J., Hunt, L., Clerehugh, V., ... & Devine, D. Dysbiosis in the oral microbiomes of anti-CCP positive individuals at risk of developing rheumatoid arthritis. Annals of the Rheumatic Diseases, 2021; 80(2), 162-168.
- Kushugulova, A., Kunz, J., Poddighe, D., & Ainabekova, B. Gut Microbiota in Elderly Onset Rheumatoid Arthritis. In Gut Microbiota in Aging and Chronic Diseases , 2023;(pp. 175-192). Cham: Springer International Publishing.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Haneen Jasim, Thanaa Al-Turaihi, Zainab Hadi, Jawad abbas
This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
